DTIL Precision Biosciences Inc.

Fundamentals / CIK 0001357874 / USD

Precision Biosciences Inc. reported $45.04M in revenue and a net loss of $38.55M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -80.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DTIL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$1.07B$533.2M$0-$195.3MFY 2018 Revenue: $10.88MFY 2018 Net Income: -$46.04M2018FY 2019 Revenue: $1.07BFY 2019 Net Income: -$92.88M2019FY 2020 Revenue: $24.29MFY 2020 Net Income: -$109.0M2020FY 2021 Revenue: $115.5MFY 2021 Net Income: -$30.60M2021FY 2022 Revenue: $25.10MFY 2022 Net Income: -$111.6M2022FY 2023 Revenue: $48.73MFY 2023 Net Income: -$61.32M2023FY 2024 Revenue: $68.70MFY 2024 Net Income: $7.17M2024FY 2025 Revenue: $34.26MFY 2025 Net Income: -$45.72M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $34.26M $68.70M $48.73M $25.10M $115.5M $24.29M $1.07B $10.88M
Research & Development $54.17M $59.56M $53.38M $46.12M $115.2M $98.06M $82.42M $45.12M
Total Operating Expenses $86.41M $94.86M $92.46M $87.41M $154.9M $134.1M $109.4M $58.80M
Operating Income -$52.15M -$26.16M -$43.74M -$62.31M -$39.38M -$109.8M -$87.20M -$47.91M
EBITDA -$50.68M -$22.76M -$36.92M -$54.51M -$30.39M -$101.1M -$81.89M -$45.56M
Interest Income $4.24M $6.76M $7.69M $3.47M $208K $822K $4.27M $1.88M
Interest Expense $1.42M $1.78M $2.23M $1.11M $132K -- $182K --
Income Before Tax -$45.72M $7.17M -- -- -- -- -- --
Income Tax Expense $0 $0 -- -- -- $23K -- --
Net Income -$45.72M $7.17M -$61.32M -$111.6M -$30.60M -$109.0M -$92.88M -$46.04M
Basic EPS -$3.56 $1.05 -$15.96 -$1.27 -$0.52 -$2.09 -$2.21 -$2.92
Diluted EPS -$3.56 $1.04 -$15.96 -$1.27 -$0.52 -$2.09 -$2.21 -$2.92
Basic Shares Outstanding 12.8M 6.8M 3.8M 87.9M 58.6M 52.0M 41.9M 15.8M
Diluted Shares Outstanding 12.8M 6.9M 3.8M 87.9M 58.6M 52.0M 41.9M 15.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $10.84M $34.20M $13K $18K $29K $638K
Research & Development $12.74M $12.39M $13.11M $14.46M $13.35M $12.77M $13.59M $15.91M
Total Operating Expenses $20.43M $19.16M $19.91M $21.70M $20.68M $21.89M $22.14M $25.48M
Operating Income -$20.43M -$19.16M -$9.07M $12.51M -$20.67M -$21.88M -$22.11M -$24.85M
EBITDA -$20.21M -$18.91M -$8.78M $12.85M -$20.32M -$21.50M -$21.72M -$24.39M
Interest Income $881K $943K $999K $773K $1.03M $1.12M $1.32M $1.49M
Interest Expense $307K $300K $311K $348K $362K $358K $354K $392K
Net Income -$7.59M -$32.65M -$18.44M $20.13M -$21.77M -$23.52M -$20.57M -$17.75M
Basic EPS -$0.28 -$1.26 -$0.75 -- -$1.84 -$2.13 -$2.21 --
Diluted EPS -$0.28 -$1.26 -$0.75 -- -$1.84 -$2.13 -$2.21 --
Basic Shares Outstanding 27.4M 25.9M 24.6M -- 11.8M 11.0M 9.3M --
Diluted Shares Outstanding 27.4M 25.9M 24.6M -- 11.8M 11.0M 9.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $110.8M $85.90M $116.7M $189.6M $143.7M $89.80M $180.9M $103.2M
Short-Term Investments $4.76M $413K -- -- -- -- -- --
Cash & Short-Term Investments $115.6M $86.31M $116.7M $189.6M $143.7M $89.80M $180.9M $103.2M
Accounts Receivable, Net $0 $229K $901K $720K $488K $10.00M $965K $523K
Other Current Assets $45K $369K $419K $1.23M $169K $4.0K $2.32M $3.05M
Total Current Assets $118.7M $94.99M $136.4M $199.1M $161.8M $105.6M $193.7M $115.7M
Property, Plant & Equipment, Net $1.43M $3.09M $6.34M $11.81M $25.15M $35.09M $39.57M $21.15M
Intangible Assets $1.17M $622K $400K $731K $2.05M $1.37M $1.43M $1.47M
Other Non-Current Assets $206K $221K $225K $226K $4.64M $1.72M $558K $312K
Total Non-Current Assets $35.68M $41.40M $23.42M $39.06M $49.74M $44.59M $41.56M $22.93M
Total Assets $154.4M $136.4M $159.8M $238.2M $211.5M $150.2M $235.2M $138.6M
Accounts Payable $296K $1.31M $2.97M $653K $1.14M $792K $2.04M $2.22M
Deferred Revenue (Current) $0 $2.96M $12.04M $46.19M $21.24M $30.24M $16.49M $8.44M
Other Current Liabilities $649K $989K $2.39M $745K $977K $854K $1.58M --
Total Current Liabilities $8.91M $14.98M $49.99M $59.66M $35.98M $42.83M $26.93M $14.07M
Long-Term Debt -- -- -- $22.22M $2.48M -- -- --
Deferred Revenue (Non-Current) $0 $23.30M $73.08M $82.87M $67.02M $53.93M $65.89M $82.81M
Other Non-Current Liabilities $259K $194K $128K $201K $44K $392K -- --
Total Non-Current Liabilities $53.26M $65.02M $90.93M $118.1M $84.35M $62.90M $69.99M $84.56M
Total Liabilities $62.17M $80.00M $140.9M $177.7M $120.3M $105.7M $96.92M $98.64M
Total Debt (incl. Leases) $6.40M $7.72M $8.86M $27.04M $9.11M $10.52M -- --
Common Stock $1.0K $1.0K $1.0K $1.0K -- -- -- --
Retained Earnings -$528.2M -$482.5M -$489.6M -$428.3M -$316.7M -$286.1M -$177.1M -$85.19M
Total Stockholders' Equity $92.25M $56.39M $18.86M $60.43M $91.17M $44.42M $138.3M $39.96M
Total Equity $92.25M $56.39M $18.86M $60.43M $91.17M $44.42M $138.3M $39.96M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $81.70M $86.08M $99.37M $110.8M $44.87M $62.24M $77.22M $85.90M
Short-Term Investments $148K $1.47M $1.81M $4.76M $0 $0 -- $413K
Cash & Short-Term Investments $81.85M $87.55M $101.2M $115.6M $44.87M $62.24M $77.22M $86.31M
Accounts Receivable, Net $0 $0 $4.00M $0 $4.0K $0 $4.0K $229K
Other Current Assets $5.0K $5.0K $6.0K $45K $848K $427K $116K $369K
Total Current Assets $86.58M $91.55M $108.7M $118.7M $51.70M $70.26M $82.10M $94.99M
Property, Plant & Equipment, Net $779K $964K $1.18M $1.43M $2.03M $2.36M $2.72M $3.09M
Intangible Assets $1.06M $1.09M $1.13M $1.17M $985K $605K $607K $622K
Other Non-Current Assets $124K $126K $203K $206K $200K $208K $215K $221K
Total Non-Current Assets $33.80M $34.37M $35.20M $35.68M $41.80M $38.67M $42.31M $41.40M
Total Assets $120.4M $125.9M $143.9M $154.4M $93.51M $108.9M $124.4M $136.4M
Accounts Payable $813K $828K $944K $296K $1.34M $1.12M $924K $1.31M
Deferred Revenue (Current) -- -- -- $0 $6.25M $5.99M $5.73M $2.96M
Other Current Liabilities $527K $588K $858K $649K $611K $721K $896K $989K
Total Current Liabilities $8.27M $7.14M $7.75M $8.91M $15.00M $13.57M $12.39M $14.98M
Deferred Revenue (Non-Current) -- -- -- $0 $19.96M $20.23M $20.50M $23.30M
Other Non-Current Liabilities $302K $301K $324K $259K $227K $200K $197K $194K
Total Non-Current Liabilities $60.33M $73.49M $60.03M $53.26M $61.88M $61.31M $62.68M $65.02M
Total Liabilities $68.60M $80.63M $67.79M $62.17M $76.88M $74.87M $75.07M $80.00M
Total Debt (incl. Leases) $5.29M $5.68M $6.05M $6.40M $6.75M $7.09M $7.41M $7.72M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$586.9M -$579.3M -$546.6M -$528.2M -$548.3M -$526.5M -$503.0M -$482.5M
Total Stockholders' Equity $51.77M $45.29M $76.10M $92.25M $16.63M $34.05M $49.34M $56.39M
Total Equity $51.77M $45.29M $76.10M $92.25M $16.63M $34.05M $49.34M $56.39M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$45.72M $7.17M -$61.32M -$111.6M -$30.60M -$109.0M -$92.88M -$46.04M
Depreciation & Amortization $1.47M $3.40M $6.82M $7.80M $8.98M $8.78M $5.32M $2.35M
Stock-Based Compensation $10.19M $12.60M $14.04M $19.20M $16.51M $13.79M $8.94M $2.45M
Change in Receivables $229K $672K -$181K -$232K $9.51M -$9.04M -$441K -$523K
Change in Payables -$737K -$2.10M $1.51M $153K $867K -$1.46M $667K -$673K
Operating Cash Flow -$65.84M -$58.45M -$84.11M -$45.75M -$10.85M -$87.39M -$71.02M -$51.72M
Capital Expenditure -$85K -$250K -$1.96M -$3.32M -$5.05M -$5.03M -$24.67M -$14.28M
Free Cash Flow -$65.93M -$58.70M -$86.07M -$49.07M -$15.91M -$92.42M -$95.68M -$66.00M
Investing Cash Flow -$634K -$215K $5.83M -$3.32M -$5.80M -$5.03M -$24.67M -$15.66M
Common Stock Issued -- -- $4.99M $49.34M $25.48M -- -- --
Financing Cash Flow $95.16M $50.45M $5.39M $94.98M $70.52M $1.33M $173.4M $107.8M
Net Change in Cash $28.68M -$8.21M -$72.90M $45.91M $53.87M -$91.09M $77.69M $40.39M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.59M -$32.65M -$18.44M $20.13M -$21.77M -$23.52M -$20.57M -$17.75M
Depreciation & Amortization $222K $253K $299K $345K $350K $378K $395K $454K
Stock-Based Compensation $2.96M $1.84M $1.55M $2.04M $2.39M $2.94M $2.82M $3.57M
Change in Receivables $0 $4.00M -$4.00M $4.0K -$4.0K $4.0K $225K -$41K
Change in Payables -$29K -$122K $648K -$1.05M $220K $199K -$106K $72K
Operating Cash Flow -$15.13M -$13.44M -$11.94M -$11.25M -$15.27M -$20.27M -$19.05M -$18.68M
Capital Expenditure $0 $0 -$18K -$19K $0 -$2.0K -$64K -$97K
Free Cash Flow -$15.13M -$13.44M -$11.96M -$11.27M -$15.27M -$20.27M -$19.12M -$18.78M
Investing Cash Flow -$200K $1.0K -$114K -$325K $17K -$12K -$314K -$97K
Financing Cash Flow $10.96M $0 $745K $77.52M $1.66M $5.30M $10.69M $5.92M
Net Change in Cash -$4.37M -$13.44M -$11.31M $65.94M -$13.59M -$14.98M -$8.68M -$12.86M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -152.2% -38.1% -89.8% -248.3% -34.1% -452.2% -8.1% -440.2%
Net Profit Margin -133.4% 10.4% -125.8% -444.8% -26.5% -448.9% -8.7% -423.0%
Return on Equity (ROE) -49.6% 12.7% -325.1% -184.7% -33.6% -245.4% -67.1% -115.2%
Return on Assets (ROA) -29.6% 5.3% -38.4% -46.9% -14.5% -72.6% -39.5% -33.2%
Current Ratio 13.32x 6.34x 2.73x 3.34x 4.50x 2.46x 7.19x 8.22x
Quick Ratio 12.97x 5.78x 2.35x 3.19x 4.01x 2.33x 6.75x 7.37x
Debt to Equity 0.07x 0.14x 0.47x 0.45x 0.10x 0.24x -- --
Revenue Growth (YoY) -50.1% +41.0% +94.1% -78.3% +375.7% -97.7% +9731.8% --
Net Income Growth (YoY) -738.0% -- -- -- -- -- -- --
EPS Growth (YoY) -439.0% -- -- -- -- -- -- --
5Y Revenue / Share Growth +471.8% -60.6% +1736.9% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -80.3% -80.8% -86.8% -152.2% -12822.6% -7145.9% -86.2% -38.1%
Net Profit Margin -85.6% -117.0% -96.7% -133.4% -11977.4% -6205.8% -43.0% 10.4%
Return on Equity (ROE) -74.4% -116.4% -57.3% -49.6% -502.6% -229.8% -44.6% 12.7%
Return on Assets (ROA) -32.0% -41.9% -30.3% -29.6% -89.4% -71.8% -17.7% 5.3%
Current Ratio 10.47x 12.82x 14.02x 13.32x 3.45x 5.18x 6.62x 6.34x
Quick Ratio 9.90x 12.26x 13.56x 12.97x 2.99x 4.59x 6.23x 5.78x
Debt to Equity 0.10x 0.13x 0.08x 0.07x 0.41x 0.21x 0.15x 0.14x
Revenue Growth (YoY) -100.0% -100.0% +37272.4% +5261.1% -97.7% -100.0% -99.8% -90.9%
Operating Income Growth (YoY) -- -- -- -- -- -190.6% -- --
Net Income Growth (YoY) -- -- -- -- -- -171.8% -339.5% --
EPS Growth (YoY) -- -- -- -- -- -145.3% -230.0% --
Source: SEC EDGAR CompanyFacts (CIK 0001357874) · from March 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:42 UTC · Open in terminal